Jump Financial’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Jump Financial’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,776	Closed	-$238K	–	1866
2021 Q3	$238K	Sell	11,776 -17,624	-60%	-$487K	0.02%	788
2021 Q2	$1.1M	Buy	+29,400	New	+$901K	0.11%	253

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Jump Financial's DRNA Position: Q4 2021 in Review

Jump Financial sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 11,776 shares — an estimated $238K sold.

Jump Financial first reported a position in DRNA in Q2 2021 and held it in 2 quarters. The position peaked at $1.1M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Jump Financial reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Jump Financial sold 11,776 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $238K.
Jump Financial first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2021 and held it in 2 quarters.
Jump Financial's Dicerna Pharmaceuticals, Inc. position peaked at $1.1M in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Jump Financial's 13F filing for Q4 2021, filed 10 Feb 2022.